The single-use bioreactors market presents key opportunities driven by increasing demand for biopharmaceuticals, cost efficiency, and technological innovations. The market is boosted by the rising ...

Single-use biomanufacturing has shifted the default expectation for process monitoring: instead of pulling manual samples and waiting for offline analysis, modern disposable bioreactors arrive with ...

Expansion Scales U.S. Single-Use Drug Substance Capacity to 20,000 Liters Across Two FDA-Registered Facilities SAN DIEGO, CA ...

The EU has invested €6.3M ($7.2M) in the Coco-AI project, which will use artificial intelligence to develop a plant cell ...

The biopharmaceutical processing equipment & consumables market is witnessing robust growth, driven by the rising production of biologics, biosimilars, vaccines, and advanced cell and gene therapies.

SHIJIAZHUANG, China, July 9, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that its MFG8 drug ...

Samsung Biologics and Fujifilm Biotechnologies discuss how regional manufacturing, dual sourcing and networked CDMO capacity ...

Qualified Vero Master Cell Bank and Working Cell Bank, originating from WHO banks, are available for purchase, licensing, and use in ...

WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that its MFG17 drug substance facility located at the Shanghai Fengxian site ...